| Literature DB >> 19640311 |
Pei-Shan Ho1, Pai-Li Chen, Saman Warnakulasuriya, Tien-Yu Shieh, Yun-Kwan Chen, I-Yueh Huang.
Abstract
BACKGROUND: Oral squamous cell carcinoma could be preceded by clinically evident oral potentially malignant disorders (OPMDs). Transformation of OPMDs to cancer has been studied in several population groups. It is difficult to undertake comparisons across populations due to variations in the methods of computation of malignancy rates among different studies. The aim of our study was to estimate the rate of malignant transformation of OPMDs taking into account the duration of follow-up and to identify the significant factors indicative of malignant potential.Entities:
Mesh:
Year: 2009 PMID: 19640311 PMCID: PMC2734864 DOI: 10.1186/1471-2407-9-260
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.430
Malignant Transformation in OPMDs
| Age(years)1 | Mean Duration(months)2 | Duration Range3 | Malignancy(%)4 | Transformation rate(CI)5 | |
|---|---|---|---|---|---|
| Epithelial dysplasia | 46.70(11.51) | 38.18(27.90) | 6.53–101.2 | 8 (24.24) | 7.62 (2.34–12.90) |
| Verrucous hyperplasia | 46.66(11.11) | 41.87(42.47) | 6.07–185.5 | 9 (20.00) | 5.21 (1.60–8.82) |
| Hyperkeratosis or epithelial hyperplasia | 42.51(12.98) | 32.94(32.81) | 6.13–135.23 | 6 (8.57) | 3.26 (0.65–5.87) |
| OSF | 39.50(21.05) | 71.13(50.45) | 27.27–140.97 | 0 (0.00) | - |
1 The average age with standard deviation at first diagnosis
2 The average follow-up duration with standard deviation before malignant event
3 The range of follow-up duration before malignant event
4 The number and proportion of malignant transformation
5 The malignant transformation rate with 95% Confidence Interval (100 persons-year)
The Factors Related to Development of Malignancy of OPMDs(n = 148)1
| Malignant Transformation | |||||
|---|---|---|---|---|---|
| Yes | No | ||||
| N | % | N | % | P value | |
| Age | |||||
| <=45 years | 13 | 20.00 | 52 | 80.00 | |
| > 45 years | 9 | 11.39 | 70 | 88.61 | 0.1531 |
| Smoking | |||||
| No | 18 | 13.64 | 114 | 86.36 | 0.0447 |
| Yes | 4 | 36.36 | 7 | 63.64 | |
| Alcohol use | |||||
| No | 13 | 14.13 | 79 | 85.87 | 0.7273 |
| Yes | 8 | 16.33 | 41 | 83.67 | |
| Areca quid use | |||||
| No | 20 | 14.49 | 118 | 85.51 | 0.1204 |
| Yes | 2 | 40.00 | 3 | 60.00 | |
| Location | |||||
| Buccal2 | 8 | 8.25 | 89 | 91.75 | < 0.0001 |
| Tongue | 11 | 52.38 | 10 | 47.62 | |
| Other3 | 3 | 11.54 | 23 | 88.46 | |
1: OSF cases are excluded in this table
2: Including buccal, vestibule and retromolar
3: Including lip, gingiva, palate
Figure 1The Kaplan-Meir curve for cancer free survival by OPMDs.
Proportional Hazards Model of Malignant Transformation for Related Factors(n = 148)1
| Variable | RR | 95%CI | P value | ARR | 95%CI | P value | |
|---|---|---|---|---|---|---|---|
| Age | <=45 years | 1.00 | 1.00 | ||||
| > 45 years | 1.42 | (0.93,2.22) | 0.1007 | 1.42 | (0.90,2.31) | 0.1184 | |
| OPMDs | Hyperkeratosis or epithelial hyperplasia | 1.00 | 1.00 | ||||
| Verrucous hyperplasia | 1.38 | (0.81,2.44) | 0.2304 | 1.23 | (0.66,2.31) | 0.5077 | |
| Epithelial dysplasia | 1.56 | (0.92,2.82) | 0.0991 | 1.51 | (0.86,2.73) | 0.1493 | |
| Location | Buccal2 | 1.00 | 1.00 | ||||
| Tongue | 2.31 | (1.46,3.71) | < 0.001 | 2.41 | (1.43,4.16) | 0.0012 | |
| Other3 | 1.34 | (0.62,2.50) | 0.4103 | 1.37 | (0.62,2.68) | 0.4062 | |
| Smoking | No | 1.00 | 1.00 | ||||
| Yes | 0.77 | (0.47,1.44) | 0.3958 | 0.98 | (0.48,2.31) | 0.9556 | |
| Alcohol use | No | 1.00 | 1.00 | ||||
| Yes | 0.99 | (0.65,1.58) | 0.9809 | 1.10 | (0.68,1.87) | 0.7134 | |
| Areca quid use | No | 1.00 | 1.00 | ||||
| Yes | 0.53 | (0.28,1.34) | 0.1505 | 0.98 | (0.36,2.97) | 0.9682 |
1: OSF cases are excluded in this table
2: Including buccal, vestibule and retromolar
3: Including lip, gingival, palate